SlideShare a Scribd company logo
Maria Mavris
European Rare Diseases Organisation (EURORDIS), France
EUPATI 2014 Workshop, 2 April 2014, Warsaw
Break-Out Group
Presentation and discussion of Good Practice Example:
EURORDIS
The project is receiving support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n 115334, resources of which are composed
of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies.
eurordis.orgeurordis.org
Maria Mavris
Therapeutic Development Director
maria.mavris@eurordis.org
Rare Disease Day
203/04/2014
eurordis.org
EURORDIS
3
An international non-profit, non-governmental umbrella
rare disease patients’ organisation representing an
estimated 30 million individuals in Europe
Our Mission:
• To build a strong pan-European community of patient
organisations and people living with rare diseases
• To be their voice at the European level
• To directly or indirectly fight against the impact of rare
diseases on their lives
eurordis.org
EURORDIS in brief
4
• Founded in 1997
• +600 member patient organisations
• 56 countries (26 EU countries)
• 33 National Alliances of RD Patients Organisations
• 40 European Federations
• Outreach to over 1800 patient groups
• Over 4,000 rare diseases represented
• 27 staff members, offices in Paris, Brussels, Barcelona
• Approximately 130 volunteers
eurordis.org
Rare Disease Day!
eurordis.org
Where did it begin?
• A day to put Rare Diseases in the
spotlight – build awareness
• Conceived in 2006 at a
EURORDIS meeting with the
Council of National Alliances
• Executed by the Council of
National Alliances and
coordinated by EURORDIS
internationally
• Last day of February every year
since 2008
03/04/2014 6
eurordis.org
Rare Disease Day
• National Alliances are the official
partners
• Thousands of events are held
around the world in over 80
countries
• The momentum contributes to the
advancement of national plans
and strategies for rare diseases
in a number of countries in the
EU and beyond.
03/04/2014 7
eurordis.org
Targets
• General Public (and the Media)
• Patients and patient representatives
• EU and national policy makers & Health authorities
• Health professionals and care givers
• Researchers, clinicians and academics
• Pharmaceutical and biotech industry
eurordis.org
Organisation- role of EURORDIS
• Dates, themes, content
• International coordination of Rare Disease Day
• Management of graphic identity (logo, poster, visuals)
• Rare Disease Day website
• Development of common tools
• European level event
• Management of “Friends of Rare Disease Day” list
• Evaluation of results at international level
• Media monitoring
03/04/2014 9
eurordis.org
• Coordination at national level
• Updating information on www.rarediseaseday.org
• Linking national/local partners to „Friends of Rare Disease Day‟
• Adaptation of common tools
• Funding for local actions
• Press/ Media contacts
• Data gathering for evaluation
• Organisation of common features:
• Patron: video or written support message
• Reaching out to researchers
10
Role of National Alliances
eurordis.org
Additional stakeholders are invited to participate in the event:
European Federations, EUROPLAN partners, Industry, Research Networks, Regulators
Participating organisations must:
- Contact their national alliance in their country
- Coordinate their activities with the national alliance in their country
- No written agreement but by completing on-line form to become a „Friends of
Rare Disease Day‟ they accept to:
- adhere to the spirit of the campaign (no commercial use of the logo! No
product advertising!)
- link to website(s) and post logo
- help raise awareness and relay the messages of the campaign
(Names of „Friends‟ will be displayed on website)
11
Other organisations
eurordis.org
Communication tools
• Info Pack
• Logo / banner / email footer
• Social media banners and logos
• Poster
• Slogan
• Website
• Press kit
• Official video
12
eurordis.org
13
Logo
eurordis.org
14
Poster
eurordis.org
Website - Homepage
03/04/2014 15
eurordis.org
Rare Disease Day: Participating Countries
18 in 2008
30 in 2009
46 in 2010
55 in 2011….
>80 in 2014
FSGA, January 21, 2012, Sydney, Australia
eurordis.org
Website - Country page
03/04/2014 17
eurordis.org
Sharing stories and photos….
03/04/2014 18
eurordis.org
Rare Disease Day (2012) - video
03/04/2014 19
https://www.youtube.com/watch?v=LBVug-GVLg0
eurordis.org03/04/2014 20

More Related Content

What's hot

Introduction to the break out sessions & case studies presentations
Introduction to the break out sessions & case studies presentationsIntroduction to the break out sessions & case studies presentations
Introduction to the break out sessions & case studies presentations
EUPATI
 
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI
 
G1 report from breakout group 1
G1 report from breakout group 1G1 report from breakout group 1
G1 report from breakout group 1
EUPATI
 
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI
 
Introduction to the breakout sessions & case studies presentations
Introduction to the breakout sessions & case studies presentationsIntroduction to the breakout sessions & case studies presentations
Introduction to the breakout sessions & case studies presentations
EUPATI
 
Workshop 3 - "Presentation of the Epi-Rare project"
Workshop 3 - "Presentation of the Epi-Rare project"Workshop 3 - "Presentation of the Epi-Rare project"
Workshop 3 - "Presentation of the Epi-Rare project"
EURORDIS - Rare Diseases Europe
 
EUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvementEUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvement
EUPATI
 
Introduction to the workshop and EUPATI update
Introduction to the workshop and EUPATI updateIntroduction to the workshop and EUPATI update
Introduction to the workshop and EUPATI update
EUPATI
 
EUPATI Launch Meeting - Per Spindler
EUPATI Launch Meeting - Per SpindlerEUPATI Launch Meeting - Per Spindler
EUPATI Launch Meeting - Per Spindler
jangeissler
 
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
EURORDIS - Rare Diseases Europe
 
G2 report from breakout group 2
G2 report from breakout group 2G2 report from breakout group 2
G2 report from breakout group 2
EUPATI
 
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
EURORDIS - Rare Diseases Europe
 
EUPATI Launch Meeting - Jan Geissler
EUPATI Launch Meeting - Jan GeisslerEUPATI Launch Meeting - Jan Geissler
EUPATI Launch Meeting - Jan Geissler
jangeissler
 
Croi Galway - Derick Mitchell - July 2016
Croi Galway - Derick Mitchell - July 2016Croi Galway - Derick Mitchell - July 2016
Croi Galway - Derick Mitchell - July 2016
ipposi
 
Medicines Transparency in Uganda
Medicines Transparency in UgandaMedicines Transparency in Uganda
Medicines Transparency in Uganda
MeTApresents
 
Good practices in patient involvement in HTA
Good practices in patient involvement in HTAGood practices in patient involvement in HTA
Good practices in patient involvement in HTA
EUPATI
 
Francois Houyez, EURORDIS
Francois Houyez, EURORDISFrancois Houyez, EURORDIS
Francois Houyez, EURORDIS
Cittadinanzattiva onlus
 
Insight 2016 cork
Insight 2016 corkInsight 2016 cork
Insight 2016 cork
ipposi
 
Evidence to improve effectiveness
Evidence to improve effectivenessEvidence to improve effectiveness
Evidence to improve effectiveness
Roger Watson
 

What's hot (19)

Introduction to the break out sessions & case studies presentations
Introduction to the break out sessions & case studies presentationsIntroduction to the break out sessions & case studies presentations
Introduction to the break out sessions & case studies presentations
 
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
 
G1 report from breakout group 1
G1 report from breakout group 1G1 report from breakout group 1
G1 report from breakout group 1
 
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
 
Introduction to the breakout sessions & case studies presentations
Introduction to the breakout sessions & case studies presentationsIntroduction to the breakout sessions & case studies presentations
Introduction to the breakout sessions & case studies presentations
 
Workshop 3 - "Presentation of the Epi-Rare project"
Workshop 3 - "Presentation of the Epi-Rare project"Workshop 3 - "Presentation of the Epi-Rare project"
Workshop 3 - "Presentation of the Epi-Rare project"
 
EUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvementEUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvement
 
Introduction to the workshop and EUPATI update
Introduction to the workshop and EUPATI updateIntroduction to the workshop and EUPATI update
Introduction to the workshop and EUPATI update
 
EUPATI Launch Meeting - Per Spindler
EUPATI Launch Meeting - Per SpindlerEUPATI Launch Meeting - Per Spindler
EUPATI Launch Meeting - Per Spindler
 
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
 
G2 report from breakout group 2
G2 report from breakout group 2G2 report from breakout group 2
G2 report from breakout group 2
 
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
 
EUPATI Launch Meeting - Jan Geissler
EUPATI Launch Meeting - Jan GeisslerEUPATI Launch Meeting - Jan Geissler
EUPATI Launch Meeting - Jan Geissler
 
Croi Galway - Derick Mitchell - July 2016
Croi Galway - Derick Mitchell - July 2016Croi Galway - Derick Mitchell - July 2016
Croi Galway - Derick Mitchell - July 2016
 
Medicines Transparency in Uganda
Medicines Transparency in UgandaMedicines Transparency in Uganda
Medicines Transparency in Uganda
 
Good practices in patient involvement in HTA
Good practices in patient involvement in HTAGood practices in patient involvement in HTA
Good practices in patient involvement in HTA
 
Francois Houyez, EURORDIS
Francois Houyez, EURORDISFrancois Houyez, EURORDIS
Francois Houyez, EURORDIS
 
Insight 2016 cork
Insight 2016 corkInsight 2016 cork
Insight 2016 cork
 
Evidence to improve effectiveness
Evidence to improve effectivenessEvidence to improve effectiveness
Evidence to improve effectiveness
 

Similar to Rare Disease Day: Discussion of a good practice example: Mavris

Denis Costello - Cambridge Rare Disease Summit 2015
Denis Costello - Cambridge Rare Disease Summit 2015Denis Costello - Cambridge Rare Disease Summit 2015
Denis Costello - Cambridge Rare Disease Summit 2015
CamRARE Disease Network
 
Rare Disease Day 2010 report on campaign
Rare Disease Day 2010 report on campaign   Rare Disease Day 2010 report on campaign
Rare Disease Day 2010 report on campaign
EURORDIS - Rare Diseases Europe
 
2009 Convegno Malattie Rare Lipucci Di Paola [22 01]
2009 Convegno Malattie Rare Lipucci Di Paola [22 01]2009 Convegno Malattie Rare Lipucci Di Paola [22 01]
2009 Convegno Malattie Rare Lipucci Di Paola [22 01]
cmid
 
ENCA 2016 - Genoa - Dieter Wiek
ENCA 2016 - Genoa - Dieter WiekENCA 2016 - Genoa - Dieter Wiek
ENCA 2016 - Genoa - Dieter Wiek
anton gruss
 
Christel Nourissier Rare Disease Communities Intro
Christel Nourissier Rare Disease Communities IntroChristel Nourissier Rare Disease Communities Intro
Christel Nourissier Rare Disease Communities IntroMihaiela Fazacas
 
Karunkara-Keynote-msf and open data-nfdp2013
Karunkara-Keynote-msf and open data-nfdp2013Karunkara-Keynote-msf and open data-nfdp2013
Karunkara-Keynote-msf and open data-nfdp2013
DataDryad
 
Conference 4 - The patient experience in the development and implementation ...
Conference 4 - The patient experience  in the development and implementation ...Conference 4 - The patient experience  in the development and implementation ...
Conference 4 - The patient experience in the development and implementation ...
EURORDIS - Rare Diseases Europe
 
Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...
Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...
Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...
Canadian Organization for Rare Disorders
 
Rare disease day 2011 highlights
Rare disease day 2011 highlightsRare disease day 2011 highlights
Rare disease day 2011 highlights
EURORDIS - Rare Diseases Europe
 
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...A snapshot of EUPATI: Why the educated patient is so vital to success in clin...
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...
jangeissler
 
Day 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDIS
Day 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDISDay 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDIS
Day 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDIS
Canadian Organization for Rare Disorders
 
UCD Rare Disease Module 2017 - Dr Derick Mitchell - March 28th 2017
UCD Rare Disease Module 2017 - Dr Derick Mitchell - March 28th 2017UCD Rare Disease Module 2017 - Dr Derick Mitchell - March 28th 2017
UCD Rare Disease Module 2017 - Dr Derick Mitchell - March 28th 2017
ipposi
 
Iadpo membership invitation&information
Iadpo membership invitation&informationIadpo membership invitation&information
Iadpo membership invitation&information
Stephen Clarke
 
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
EURORDIS - Rare Diseases Europe
 
IRDiRC: State of the Art. By Paul Lasko, PhD
IRDiRC: State of the Art. By Paul Lasko, PhDIRDiRC: State of the Art. By Paul Lasko, PhD
IRDiRC: State of the Art. By Paul Lasko, PhD
Vall d'Hebron Institute of Research (VHIR)
 
EUPATI Status Update at EMA PCWP Meeting, 26 Nov 2015
EUPATI Status Update at EMA PCWP Meeting, 26 Nov 2015EUPATI Status Update at EMA PCWP Meeting, 26 Nov 2015
EUPATI Status Update at EMA PCWP Meeting, 26 Nov 2015
jangeissler
 
AGE Annual Report 2014
AGE Annual Report 2014AGE Annual Report 2014
AGE Annual Report 2014
RunwaySale
 
Webinar: EUPATI Update to participants of the EUPATI Focus Groups - 4 Nov 2013
Webinar: EUPATI Update to participants of the EUPATI Focus Groups - 4 Nov 2013Webinar: EUPATI Update to participants of the EUPATI Focus Groups - 4 Nov 2013
Webinar: EUPATI Update to participants of the EUPATI Focus Groups - 4 Nov 2013
EUPATI
 
The Role of Portals and Blogs in Health Communication
The Role of Portals and Blogs in Health CommunicationThe Role of Portals and Blogs in Health Communication
The Role of Portals and Blogs in Health Communication
Plan de Calidad para el SNS
 
European Patients Academy - Presentation of Jan Geissler at EPF AGM
European Patients Academy - Presentation of  Jan Geissler at EPF AGMEuropean Patients Academy - Presentation of  Jan Geissler at EPF AGM
European Patients Academy - Presentation of Jan Geissler at EPF AGM
jangeissler
 

Similar to Rare Disease Day: Discussion of a good practice example: Mavris (20)

Denis Costello - Cambridge Rare Disease Summit 2015
Denis Costello - Cambridge Rare Disease Summit 2015Denis Costello - Cambridge Rare Disease Summit 2015
Denis Costello - Cambridge Rare Disease Summit 2015
 
Rare Disease Day 2010 report on campaign
Rare Disease Day 2010 report on campaign   Rare Disease Day 2010 report on campaign
Rare Disease Day 2010 report on campaign
 
2009 Convegno Malattie Rare Lipucci Di Paola [22 01]
2009 Convegno Malattie Rare Lipucci Di Paola [22 01]2009 Convegno Malattie Rare Lipucci Di Paola [22 01]
2009 Convegno Malattie Rare Lipucci Di Paola [22 01]
 
ENCA 2016 - Genoa - Dieter Wiek
ENCA 2016 - Genoa - Dieter WiekENCA 2016 - Genoa - Dieter Wiek
ENCA 2016 - Genoa - Dieter Wiek
 
Christel Nourissier Rare Disease Communities Intro
Christel Nourissier Rare Disease Communities IntroChristel Nourissier Rare Disease Communities Intro
Christel Nourissier Rare Disease Communities Intro
 
Karunkara-Keynote-msf and open data-nfdp2013
Karunkara-Keynote-msf and open data-nfdp2013Karunkara-Keynote-msf and open data-nfdp2013
Karunkara-Keynote-msf and open data-nfdp2013
 
Conference 4 - The patient experience in the development and implementation ...
Conference 4 - The patient experience  in the development and implementation ...Conference 4 - The patient experience  in the development and implementation ...
Conference 4 - The patient experience in the development and implementation ...
 
Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...
Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...
Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...
 
Rare disease day 2011 highlights
Rare disease day 2011 highlightsRare disease day 2011 highlights
Rare disease day 2011 highlights
 
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...A snapshot of EUPATI: Why the educated patient is so vital to success in clin...
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...
 
Day 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDIS
Day 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDISDay 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDIS
Day 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDIS
 
UCD Rare Disease Module 2017 - Dr Derick Mitchell - March 28th 2017
UCD Rare Disease Module 2017 - Dr Derick Mitchell - March 28th 2017UCD Rare Disease Module 2017 - Dr Derick Mitchell - March 28th 2017
UCD Rare Disease Module 2017 - Dr Derick Mitchell - March 28th 2017
 
Iadpo membership invitation&information
Iadpo membership invitation&informationIadpo membership invitation&information
Iadpo membership invitation&information
 
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
Conference 1 - EURORDIS’ recommendations for National Plans, Yann le Cam, EUR...
 
IRDiRC: State of the Art. By Paul Lasko, PhD
IRDiRC: State of the Art. By Paul Lasko, PhDIRDiRC: State of the Art. By Paul Lasko, PhD
IRDiRC: State of the Art. By Paul Lasko, PhD
 
EUPATI Status Update at EMA PCWP Meeting, 26 Nov 2015
EUPATI Status Update at EMA PCWP Meeting, 26 Nov 2015EUPATI Status Update at EMA PCWP Meeting, 26 Nov 2015
EUPATI Status Update at EMA PCWP Meeting, 26 Nov 2015
 
AGE Annual Report 2014
AGE Annual Report 2014AGE Annual Report 2014
AGE Annual Report 2014
 
Webinar: EUPATI Update to participants of the EUPATI Focus Groups - 4 Nov 2013
Webinar: EUPATI Update to participants of the EUPATI Focus Groups - 4 Nov 2013Webinar: EUPATI Update to participants of the EUPATI Focus Groups - 4 Nov 2013
Webinar: EUPATI Update to participants of the EUPATI Focus Groups - 4 Nov 2013
 
The Role of Portals and Blogs in Health Communication
The Role of Portals and Blogs in Health CommunicationThe Role of Portals and Blogs in Health Communication
The Role of Portals and Blogs in Health Communication
 
European Patients Academy - Presentation of Jan Geissler at EPF AGM
European Patients Academy - Presentation of  Jan Geissler at EPF AGMEuropean Patients Academy - Presentation of  Jan Geissler at EPF AGM
European Patients Academy - Presentation of Jan Geissler at EPF AGM
 

More from Nowgen

Involvepresentation
InvolvepresentationInvolvepresentation
Involvepresentation
Nowgen
 
Brookman final last 5 nov
Brookman final last 5 nov Brookman final last 5 nov
Brookman final last 5 nov
Nowgen
 
Sireau eupati presentation for webinar v2
Sireau eupati presentation for webinar v2Sireau eupati presentation for webinar v2
Sireau eupati presentation for webinar v2
Nowgen
 
Pavitt ppi impact on clinical research vs1
Pavitt ppi impact on clinical research vs1Pavitt ppi impact on clinical research vs1
Pavitt ppi impact on clinical research vs1
Nowgen
 
S brookman may eupati webinar final 5 nov
S brookman may eupati webinar final 5 novS brookman may eupati webinar final 5 nov
S brookman may eupati webinar final 5 nov
Nowgen
 
Introduction to the Workshop & Participant Statistics
Introduction to the Workshop & Participant StatisticsIntroduction to the Workshop & Participant Statistics
Introduction to the Workshop & Participant Statistics
Nowgen
 
Involving People: Patients, Participants & Consumers in U.K.Cancer Research (...
Involving People: Patients, Participants & Consumers in U.K.Cancer Research (...Involving People: Patients, Participants & Consumers in U.K.Cancer Research (...
Involving People: Patients, Participants & Consumers in U.K.Cancer Research (...
Nowgen
 
Working with young people to shape research – reaping the benefits & the impo...
Working with young people to shape research – reaping the benefits & the impo...Working with young people to shape research – reaping the benefits & the impo...
Working with young people to shape research – reaping the benefits & the impo...
Nowgen
 
Patients at the Centre for Health Research – Patient, Carer and Public Invol...
Patients at the Centre for Health Research –  Patient, Carer and Public Invol...Patients at the Centre for Health Research –  Patient, Carer and Public Invol...
Patients at the Centre for Health Research – Patient, Carer and Public Invol...
Nowgen
 
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)
Nowgen
 
Patient involvement in clinical research and long term conditions -what can b...
Patient involvement in clinical research and long term conditions -what can b...Patient involvement in clinical research and long term conditions -what can b...
Patient involvement in clinical research and long term conditions -what can b...
Nowgen
 
Patients at the core of medical research & development (Emma Law, Scottish De...
Patients at the core of medical research & development (Emma Law, Scottish De...Patients at the core of medical research & development (Emma Law, Scottish De...
Patients at the core of medical research & development (Emma Law, Scottish De...
Nowgen
 
Bringing the patient voice into GSK for educational, awareness and patient ce...
Bringing the patient voice into GSK for educational, awareness and patient ce...Bringing the patient voice into GSK for educational, awareness and patient ce...
Bringing the patient voice into GSK for educational, awareness and patient ce...
Nowgen
 
Patient involvement in medicines development – the views of patients and key ...
Patient involvement in medicines development – the views of patients and key ...Patient involvement in medicines development – the views of patients and key ...
Patient involvement in medicines development – the views of patients and key ...
Nowgen
 
EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)
EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)
EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)
Nowgen
 

More from Nowgen (15)

Involvepresentation
InvolvepresentationInvolvepresentation
Involvepresentation
 
Brookman final last 5 nov
Brookman final last 5 nov Brookman final last 5 nov
Brookman final last 5 nov
 
Sireau eupati presentation for webinar v2
Sireau eupati presentation for webinar v2Sireau eupati presentation for webinar v2
Sireau eupati presentation for webinar v2
 
Pavitt ppi impact on clinical research vs1
Pavitt ppi impact on clinical research vs1Pavitt ppi impact on clinical research vs1
Pavitt ppi impact on clinical research vs1
 
S brookman may eupati webinar final 5 nov
S brookman may eupati webinar final 5 novS brookman may eupati webinar final 5 nov
S brookman may eupati webinar final 5 nov
 
Introduction to the Workshop & Participant Statistics
Introduction to the Workshop & Participant StatisticsIntroduction to the Workshop & Participant Statistics
Introduction to the Workshop & Participant Statistics
 
Involving People: Patients, Participants & Consumers in U.K.Cancer Research (...
Involving People: Patients, Participants & Consumers in U.K.Cancer Research (...Involving People: Patients, Participants & Consumers in U.K.Cancer Research (...
Involving People: Patients, Participants & Consumers in U.K.Cancer Research (...
 
Working with young people to shape research – reaping the benefits & the impo...
Working with young people to shape research – reaping the benefits & the impo...Working with young people to shape research – reaping the benefits & the impo...
Working with young people to shape research – reaping the benefits & the impo...
 
Patients at the Centre for Health Research – Patient, Carer and Public Invol...
Patients at the Centre for Health Research –  Patient, Carer and Public Invol...Patients at the Centre for Health Research –  Patient, Carer and Public Invol...
Patients at the Centre for Health Research – Patient, Carer and Public Invol...
 
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)
 
Patient involvement in clinical research and long term conditions -what can b...
Patient involvement in clinical research and long term conditions -what can b...Patient involvement in clinical research and long term conditions -what can b...
Patient involvement in clinical research and long term conditions -what can b...
 
Patients at the core of medical research & development (Emma Law, Scottish De...
Patients at the core of medical research & development (Emma Law, Scottish De...Patients at the core of medical research & development (Emma Law, Scottish De...
Patients at the core of medical research & development (Emma Law, Scottish De...
 
Bringing the patient voice into GSK for educational, awareness and patient ce...
Bringing the patient voice into GSK for educational, awareness and patient ce...Bringing the patient voice into GSK for educational, awareness and patient ce...
Bringing the patient voice into GSK for educational, awareness and patient ce...
 
Patient involvement in medicines development – the views of patients and key ...
Patient involvement in medicines development – the views of patients and key ...Patient involvement in medicines development – the views of patients and key ...
Patient involvement in medicines development – the views of patients and key ...
 
EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)
EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)
EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)
 

Recently uploaded

Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
ranishasharma67
 
Health Education on prevention of hypertension
Health Education on prevention of hypertensionHealth Education on prevention of hypertension
Health Education on prevention of hypertension
Radhika kulvi
 
Navigating Healthcare with Telemedicine
Navigating Healthcare with  TelemedicineNavigating Healthcare with  Telemedicine
Navigating Healthcare with Telemedicine
Iris Thiele Isip-Tan
 
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfCHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
Sachin Sharma
 
Introduction to Forensic Pathology course
Introduction to Forensic Pathology courseIntroduction to Forensic Pathology course
Introduction to Forensic Pathology course
fprxsqvnz5
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
pubrica101
 
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondEmpowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Health Catalyst
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Rommel Luis III Israel
 
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
preciousstephanie75
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Guillermo Rivera
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
pchutichetpong
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
RitonDeb1
 
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
samahesh1
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
ssuser787e5c1
 
Navigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and BeyondNavigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and Beyond
Aboud Health Group
 
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
rajkumar669520
 
Telehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptxTelehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptx
The Harvest Clinic
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
The Lifesciences Magazine
 
The Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your LifeThe Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your Life
ranishasharma67
 
Yemen National Tuberculosis Program .ppt
Yemen National Tuberculosis Program .pptYemen National Tuberculosis Program .ppt
Yemen National Tuberculosis Program .ppt
Esam43
 

Recently uploaded (20)

Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
 
Health Education on prevention of hypertension
Health Education on prevention of hypertensionHealth Education on prevention of hypertension
Health Education on prevention of hypertension
 
Navigating Healthcare with Telemedicine
Navigating Healthcare with  TelemedicineNavigating Healthcare with  Telemedicine
Navigating Healthcare with Telemedicine
 
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfCHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
 
Introduction to Forensic Pathology course
Introduction to Forensic Pathology courseIntroduction to Forensic Pathology course
Introduction to Forensic Pathology course
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
 
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondEmpowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
 
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
 
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
 
Navigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and BeyondNavigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and Beyond
 
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
 
Telehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptxTelehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptx
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
 
The Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your LifeThe Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your Life
 
Yemen National Tuberculosis Program .ppt
Yemen National Tuberculosis Program .pptYemen National Tuberculosis Program .ppt
Yemen National Tuberculosis Program .ppt
 

Rare Disease Day: Discussion of a good practice example: Mavris

  • 1. Maria Mavris European Rare Diseases Organisation (EURORDIS), France EUPATI 2014 Workshop, 2 April 2014, Warsaw Break-Out Group Presentation and discussion of Good Practice Example: EURORDIS The project is receiving support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n 115334, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies.
  • 2. eurordis.orgeurordis.org Maria Mavris Therapeutic Development Director maria.mavris@eurordis.org Rare Disease Day 203/04/2014
  • 3. eurordis.org EURORDIS 3 An international non-profit, non-governmental umbrella rare disease patients’ organisation representing an estimated 30 million individuals in Europe Our Mission: • To build a strong pan-European community of patient organisations and people living with rare diseases • To be their voice at the European level • To directly or indirectly fight against the impact of rare diseases on their lives
  • 4. eurordis.org EURORDIS in brief 4 • Founded in 1997 • +600 member patient organisations • 56 countries (26 EU countries) • 33 National Alliances of RD Patients Organisations • 40 European Federations • Outreach to over 1800 patient groups • Over 4,000 rare diseases represented • 27 staff members, offices in Paris, Brussels, Barcelona • Approximately 130 volunteers
  • 6. eurordis.org Where did it begin? • A day to put Rare Diseases in the spotlight – build awareness • Conceived in 2006 at a EURORDIS meeting with the Council of National Alliances • Executed by the Council of National Alliances and coordinated by EURORDIS internationally • Last day of February every year since 2008 03/04/2014 6
  • 7. eurordis.org Rare Disease Day • National Alliances are the official partners • Thousands of events are held around the world in over 80 countries • The momentum contributes to the advancement of national plans and strategies for rare diseases in a number of countries in the EU and beyond. 03/04/2014 7
  • 8. eurordis.org Targets • General Public (and the Media) • Patients and patient representatives • EU and national policy makers & Health authorities • Health professionals and care givers • Researchers, clinicians and academics • Pharmaceutical and biotech industry
  • 9. eurordis.org Organisation- role of EURORDIS • Dates, themes, content • International coordination of Rare Disease Day • Management of graphic identity (logo, poster, visuals) • Rare Disease Day website • Development of common tools • European level event • Management of “Friends of Rare Disease Day” list • Evaluation of results at international level • Media monitoring 03/04/2014 9
  • 10. eurordis.org • Coordination at national level • Updating information on www.rarediseaseday.org • Linking national/local partners to „Friends of Rare Disease Day‟ • Adaptation of common tools • Funding for local actions • Press/ Media contacts • Data gathering for evaluation • Organisation of common features: • Patron: video or written support message • Reaching out to researchers 10 Role of National Alliances
  • 11. eurordis.org Additional stakeholders are invited to participate in the event: European Federations, EUROPLAN partners, Industry, Research Networks, Regulators Participating organisations must: - Contact their national alliance in their country - Coordinate their activities with the national alliance in their country - No written agreement but by completing on-line form to become a „Friends of Rare Disease Day‟ they accept to: - adhere to the spirit of the campaign (no commercial use of the logo! No product advertising!) - link to website(s) and post logo - help raise awareness and relay the messages of the campaign (Names of „Friends‟ will be displayed on website) 11 Other organisations
  • 12. eurordis.org Communication tools • Info Pack • Logo / banner / email footer • Social media banners and logos • Poster • Slogan • Website • Press kit • Official video 12
  • 16. eurordis.org Rare Disease Day: Participating Countries 18 in 2008 30 in 2009 46 in 2010 55 in 2011…. >80 in 2014 FSGA, January 21, 2012, Sydney, Australia
  • 17. eurordis.org Website - Country page 03/04/2014 17
  • 18. eurordis.org Sharing stories and photos…. 03/04/2014 18
  • 19. eurordis.org Rare Disease Day (2012) - video 03/04/2014 19 https://www.youtube.com/watch?v=LBVug-GVLg0